Literature DB >> 28039786

DNA interaction, antimicrobial, antioxidant and anticancer studies on Cu(II) complexes of Luotonin A.

M P Kesavan1, G G Vinoth Kumar1, J Dhaveethu Raja2, K Anitha3, S Karthikeyan4, J Rajesh5.   

Abstract

Luotonin A (L), a novel natural cytotoxic and anti-inflammatory alkaloid, chelated with copper(II) to improve its cytotoxic effect against the cancer cells. The complexes [Cu(L)H2OCl]Cl (1) and [Cu(L)2]Cl2 (2) are prepared by using copper(II) chloride and L with ligand/metal molar ratio of 1:1 and 2:1 respectively. A solution of complexes 1 &amp;2 are characterized by physical spectroscopic methods using Ultraviolet-visible (UV-Vis) spectrophotometer, Fourier Transform-Infra red (FT-IR) spectroscopy, Electron Para magnetic Resonance Spectroscopy (EPR) and by electrochemical methods. The interaction of these complexes 1 &amp;2 with calf thymus (CT-DNA) have been investigated by physical methods to propose the modes of DNA binding with the complexes 1 &amp;2. Absorption spectral titration studies of complex 1 with CT-DNA shows a red-shift of 5nm with the DNA binding affinity of Kb, 8.65×103M-1, but complex 2does not show any red-shift with binding constant Kb, 7.32×103M-1 reveals that the complex 1 binding with DNA strongly than complex 2 and the binding occurs in between the base pairs of DNA as intercalation. Strong interactions of the two complexes 1 &amp; 2 with CT-DNA have also been confirmed by fluorescence spectral titration studies. The evaluated values of KSV and Kass shows that, the complexes 1 &amp;2 interact with DNA through the intercalation, coincide with other partial intercalators strongly than the free ligand L. Complex 1 exhibits potent antioxidant activity with SC50 value of 23.9±0.69μM is evaluated by DPPH radical scavenging assay and which has potent antimicrobial activity against pathogens than 2 and L. The anticancer activity of L, complexes 1 &amp;2 against human breast cancer cell line (MCF-7) and cervical cancer cell line (HeLa) has also been studied by using fluorescence staining method. The IC50 values of L, complexes 1&amp;2 against MCF-7 and HeLa cell lines with the incubation time intervals of 24hrs are 1 (5.0±0.25, 12.0±0.30μM)<2 (6.5±0.27, 15.0±0.30μM)<L (7.0±0.15, 25.0±0.35μM) respectively. Interestingly, complex 1 exhibits anticancer activity more potent than L against both MCF-7 and HeLa cell lines. The result of anticancer activity studies show that the cytotoxic activity of L against MCF-7 and HeLa cells is increased, when chelated with Cu(II).
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticancer; Antimicrobial; Antioxidant; Cu(II) complexes; DNA binding; Luotonin A

Mesh:

Substances:

Year:  2016        PMID: 28039786     DOI: 10.1016/j.jphotobiol.2016.11.024

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  3 in total

1.  DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.

Authors:  Sidhali U Parsekar; Joseph Fernandes; Arnab Banerjee; Om Prakash Chouhan; Sumit Biswas; Manohar Singh; Durga P Mishra; Manjuri Kumar
Journal:  J Biol Inorg Chem       Date:  2018-10-09       Impact factor: 3.358

2.  Spectroscopic, Computational, Antimicrobial, DNA Interaction, In Vitro Anticancer and Molecular Docking Properties of Biochemically Active Cu(II) and Zn(II) Complexes of Pyrimidine-Ligand.

Authors:  Murugesan Sankarganesh; Jeyaraj Dhaveethu Raja; Paul Raj Adwin Jose; Gujuluva Gangatharan Vinoth Kumar; Jegathalaprathaban Rajesh; Ramalingam Rajasekaran
Journal:  J Fluoresc       Date:  2018-06-30       Impact factor: 2.217

3.  Design and synthesis of C-aryl angular luotonins via a one-pot aza-Nazarov-Friedlander sequence and their Topo-I inhibition studies along with C-aryl vasicinones and luotonins.

Authors:  Sivappa Rasapalli; Vamshikrishna Reddy Sammeta; Zachary F Murphy; James A Golen; Keli Agama; Yves Pommier; Sergey N Savinov
Journal:  Bioorg Med Chem Lett       Date:  2021-03-30       Impact factor: 2.940

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.